- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02752802
DyeVert System RCT
Single Site Randomized Control Trial Evaluating the DyeVert System
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This is a prospective, randomized, parallel group, single center clinical evaluation of the DyeVert System. Subjects undergoing a diagnostic coronary angiogram procedure with a 5 French catheter are eligible to participate in this study. The treatment group will use the DyeVert System.
The trial will be conducted at one center, located in Germany. A sample size of 96 evaluable subjects will provide a sufficient number of samples to evaluate the primary objectives.
Randomization will occur following confirmation that the subject meets the inclusion/exclusion criteria and has signed an informed consent. Subjects that are anticipated to be a diagnostic only procedure, but end up being an ad-hoc PCI, can still remain enrolled in the trial. If a subject proceeds to a PCI, data will only be collected through the diagnostic portion of the case.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Lübeck, Tyskland, 23538
- University Hospital of Schleswig-Holstein
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- The subject is indicated for a diagnostic coronary angiogram procedure with a 5 French catheter only.
- The subject is ≥ 18 years of age
- The subject is willing and able to provide appropriate informed consent.
Exclusion Criteria:
- Subject is undergoing a STEMI procedure
- Subject has previously been diagnosed with anomalous coronary anatomy
- Subject has previously underwent coronary artery bypass grafting
- Subject has severe peripheral artery disease at access site
- Subject is having a staged PCI
- The subject is female and currently pregnant
- In the investigator's opinion, the subject is not considered to be a suitable candidate
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: Treatment
The treatment group will include standard of care for diagnostic angiogram along with the utilizization of the DyeVert system.
|
Diagnostic angiographic procedure with the use of the DyeVert System.
|
Aktiv komparator: Control
The control group will include standard of care for diagnostic coronary angiograms.
|
Diagnostic angiographic procedure with the use of the DyeVert System.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Evaluate the Total Volume of CM Used Comparing the DyeVert Group to the Control Group.
Tidsramme: All data will be collected on the day of the procedure, over an average of 12 hours.
|
DyeVert is intended to reduce the total amount of contrast media (CM) administered during procedures requiring the injection of contrast media.
Clinical evidence has demonstrated that CM can be toxic to the kidneys, leading to contrast induced nephropathy (CIN)
|
All data will be collected on the day of the procedure, over an average of 12 hours.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Assessment of the Quality of Angiographic Images Between Groups
Tidsramme: AlAll data will be collected on the day of the procedure, over an average of 12 hours.
|
To assess the adequacy of the image quality.
The proportion of images in which contrast opacification is deemed sufficient to evaluate the desired anatomical structures adequately will be compared between the DyeVert and control groups.
|
AlAll data will be collected on the day of the procedure, over an average of 12 hours.
|
Assessment of Incidence of Serious Adverse Device Effect for Subjects Treated With the DyeVert System During the Procedure.
Tidsramme: All data will be collected on the day of the procedure, over an average of 12 hours.
|
To assess the incidence of Serious Adverse Device Effect for subjects treated with the DyeVert System during the procedure for treatment subjects only.
|
All data will be collected on the day of the procedure, over an average of 12 hours.
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Steffen Desch, MD, University Hospital of Schleswig-Holstein, Lubeck
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Lameire N, Kellum JA; KDIGO AKI Guideline Work Group. Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). Crit Care. 2013 Feb 4;17(1):205. doi: 10.1186/cc11455.
- Brown JR, Solomon RJ, Sarnak MJ, McCullough PA, Splaine ME, Davies L, Ross CS, Dauerman HL, Stender JL, Conley SM, Robb JF, Chaisson K, Boss R, Lambert P, Goldberg DJ, Lucier D, Fedele FA, Kellett MA, Horton S, Phillips WJ, Downs C, Wiseman A, MacKenzie TA, Malenka DJ; Northern New England Cardiovascular Disease Study Group. Reducing contrast-induced acute kidney injury using a regional multicenter quality improvement intervention. Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):693-700. doi: 10.1161/CIRCOUTCOMES.114.000903. Epub 2014 Jul 29.
- Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000 Nov 1;36(5):1542-8. doi: 10.1016/s0735-1097(00)00917-7.
- Klein LW, Sheldon MW, Brinker J, Mixon TA, Skelding K, Strunk AO, Tommaso CL, Weiner B, Bailey SR, Uretsky B, Kern M, Laskey W; Interventional Committee of the Society for Cardiovascular Angiography and Interventions. The use of radiographic contrast media during PCI: a focused review: a position statement of the Society of Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2009 Nov 1;74(5):728-46. doi: 10.1002/ccd.22113. No abstract available.
- Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996 May 15;275(19):1489-94.
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- TP-6495
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Koronar angiografi
-
IRCCS Policlinico S. DonatoRekrutteringAnomalous aortic origin of the coronary artery (AAOCA)Italia
-
Medtronic CardiovascularFullførtArteriosclerosis of coronary artery bypass graftCanada, Forente stater
-
Lawson Health Research InstituteFullførtArteriosclerosis of arterial coronary artery bypass graftCanada
-
Deutsches Herzzentrum MuenchenFullførtArteriosclerosis of arterial coronary artery bypass graftTyskland
-
Izmir Bakircay UniversityFullførtMyocardial Bridge of Coronary ArteryTyrkia
-
William Beaumont HospitalsFullførtKoronararteriesykdom | Arteriosclerosis of coronary artery bypass graftForente stater
-
ITAB - Institute for Advanced Biomedical TechnologiesAzienda Ospedaliero, Universitaria Ospedali RiunitiFullførtMyocardial Bridge of Coronary ArteryItalia
Kliniske studier på Diagnostic Coronary Angiogram
-
University of MichiganFullførtKoronararteriesykdom | PsoriasisForente stater
-
Ottawa Hospital Research InstituteThe Ottawa HospitalFullført
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceFullførtHjertestans utenfor sykehusFrankrike
-
AUM Cardiovascular, Inc.FullførtKoronararteriesykdomForente stater
-
Papworth Hospital NHS Foundation TrustCambridge University Hospitals NHS Foundation TrustHar ikke rekruttert ennå
-
University of ValenciaInstituto de Salud Carlos IIIFullførtAkutt koronarsyndromSpania
-
Charite University, Berlin, GermanyFullført
-
Guy's and St Thomas' NHS Foundation TrustUkjentKoronararteriesykdom | Brystsmerter | Akutt koronarsyndrom | Iskemisk hjertesykdomStorbritannia
-
Yeditepe UniversityDr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research...FullførtHjerteinfarkt | Koronararteriesykdom | Akutt koronarsyndromTyrkia
-
University of Texas Southwestern Medical CenterFullførtAkutt brystsmerterForente stater